Cargando…
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China
BACKGROUND: Coronavirus disease 2019 (COVID-19) has rapidly become a major international public health concern. This study was designed to evaluate the clinical characteristics and risk factors of COVID-19-associated liver injury. METHODS: A fraction of 657 COVID-19 patients were retrospectively ana...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539280/ https://www.ncbi.nlm.nih.gov/pubmed/33026573 http://dx.doi.org/10.1007/s12072-020-10075-5 |
_version_ | 1783591027135741952 |
---|---|
author | Wang, Ming Yan, Weiming Qi, Weipeng Wu, Di Zhu, Lin Li, Weina Wang, Xiaojing Ma, Ke Ni, Ming Xu, Dong Wang, Hongwu Chen, Guang Yu, Haijing Ding, Hongfang Xing, Mingyou Han, Meifang Luo, Xiaoping Chen, Tao Guo, Wei Xi, Dong Ning, Qin |
author_facet | Wang, Ming Yan, Weiming Qi, Weipeng Wu, Di Zhu, Lin Li, Weina Wang, Xiaojing Ma, Ke Ni, Ming Xu, Dong Wang, Hongwu Chen, Guang Yu, Haijing Ding, Hongfang Xing, Mingyou Han, Meifang Luo, Xiaoping Chen, Tao Guo, Wei Xi, Dong Ning, Qin |
author_sort | Wang, Ming |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) has rapidly become a major international public health concern. This study was designed to evaluate the clinical characteristics and risk factors of COVID-19-associated liver injury. METHODS: A fraction of 657 COVID-19 patients were retrospectively analyzed. Clinical and laboratory data were derived from electronic medical records and compared between patients with or without liver injury. Multivariate logistic regression method was used to analyze the risk factors for liver injury. RESULTS: Among 657 patients, 303 (46.1%) patients had liver injury with higher rate in severe/critically ill patients [148/257 (57.6%)] than those in moderate cases [155/400 (38.8%)]. The incidence of liver injury was much higher in male [192/303 (63.4%)] than female [111/303 (36.6%)], and in severe/critical patients [148/303 (48.8%)] with percutaneous oxygen saturation ≤ 93% [89/279 (31.9%)] or peak body temperature ≥ 38.5 °C [185/301 (61.5%)] on admission. Liver injury-related inflammations included increased white blood cells, neutrophils and decreased lymphocytes. More patients with liver injury than without had increased serum IL-2R, TNFα, ferritin, hsCRP, PCT, ESR, γ-GT, and LDH. Multivariate regression analysis revealed that increasing odds of liver injury were related to male, higher serum hsCRP (≥ 10 mg/L), and neutrophil-to-lymphocyte ratio (NLR) (≥ 5). Moreover, more deceased patients (14/82 (17%)) had significantly elevated serum TBIL than discharged patients [25/532 (4.7%)]. CONCLUSION: Liver injury is a common complication in COVID-19 patients. The potential risk factors of liver injury include male, hsCRP and NLR score. A close monitor of liver function should be warned in COVID-19 patients, especially in severe/critical individuals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12072-020-10075-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7539280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-75392802020-10-07 Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China Wang, Ming Yan, Weiming Qi, Weipeng Wu, Di Zhu, Lin Li, Weina Wang, Xiaojing Ma, Ke Ni, Ming Xu, Dong Wang, Hongwu Chen, Guang Yu, Haijing Ding, Hongfang Xing, Mingyou Han, Meifang Luo, Xiaoping Chen, Tao Guo, Wei Xi, Dong Ning, Qin Hepatol Int Original Article BACKGROUND: Coronavirus disease 2019 (COVID-19) has rapidly become a major international public health concern. This study was designed to evaluate the clinical characteristics and risk factors of COVID-19-associated liver injury. METHODS: A fraction of 657 COVID-19 patients were retrospectively analyzed. Clinical and laboratory data were derived from electronic medical records and compared between patients with or without liver injury. Multivariate logistic regression method was used to analyze the risk factors for liver injury. RESULTS: Among 657 patients, 303 (46.1%) patients had liver injury with higher rate in severe/critically ill patients [148/257 (57.6%)] than those in moderate cases [155/400 (38.8%)]. The incidence of liver injury was much higher in male [192/303 (63.4%)] than female [111/303 (36.6%)], and in severe/critical patients [148/303 (48.8%)] with percutaneous oxygen saturation ≤ 93% [89/279 (31.9%)] or peak body temperature ≥ 38.5 °C [185/301 (61.5%)] on admission. Liver injury-related inflammations included increased white blood cells, neutrophils and decreased lymphocytes. More patients with liver injury than without had increased serum IL-2R, TNFα, ferritin, hsCRP, PCT, ESR, γ-GT, and LDH. Multivariate regression analysis revealed that increasing odds of liver injury were related to male, higher serum hsCRP (≥ 10 mg/L), and neutrophil-to-lymphocyte ratio (NLR) (≥ 5). Moreover, more deceased patients (14/82 (17%)) had significantly elevated serum TBIL than discharged patients [25/532 (4.7%)]. CONCLUSION: Liver injury is a common complication in COVID-19 patients. The potential risk factors of liver injury include male, hsCRP and NLR score. A close monitor of liver function should be warned in COVID-19 patients, especially in severe/critical individuals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12072-020-10075-5) contains supplementary material, which is available to authorized users. Springer India 2020-10-07 /pmc/articles/PMC7539280/ /pubmed/33026573 http://dx.doi.org/10.1007/s12072-020-10075-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Wang, Ming Yan, Weiming Qi, Weipeng Wu, Di Zhu, Lin Li, Weina Wang, Xiaojing Ma, Ke Ni, Ming Xu, Dong Wang, Hongwu Chen, Guang Yu, Haijing Ding, Hongfang Xing, Mingyou Han, Meifang Luo, Xiaoping Chen, Tao Guo, Wei Xi, Dong Ning, Qin Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title | Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title_full | Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title_fullStr | Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title_full_unstemmed | Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title_short | Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China |
title_sort | clinical characteristics and risk factors of liver injury in covid-19: a retrospective cohort study from wuhan, china |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539280/ https://www.ncbi.nlm.nih.gov/pubmed/33026573 http://dx.doi.org/10.1007/s12072-020-10075-5 |
work_keys_str_mv | AT wangming clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT yanweiming clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT qiweipeng clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT wudi clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT zhulin clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT liweina clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT wangxiaojing clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT make clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT niming clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT xudong clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT wanghongwu clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT chenguang clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT yuhaijing clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT dinghongfang clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT xingmingyou clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT hanmeifang clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT luoxiaoping clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT chentao clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT guowei clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT xidong clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina AT ningqin clinicalcharacteristicsandriskfactorsofliverinjuryincovid19aretrospectivecohortstudyfromwuhanchina |